Phase 2 trial of AMG 386 for treatment of recurrent ovarian cancer - ONA
Links shared publicly online about this topic.
- 1,111total visits
Phase 2 trial of AMG 386 for treatment of recurrent ovarian cancer - ONA
View full resource at oncologynurseadvisor.com
Tags: Cancer, Cancer Medication, Ovarian Cancer, Phase 2 Clinical Trial, Women's Health, Taxol, Amgen
Most Recently Shared on June 7, 2010 at 8:20 pm By:
Phase 2 trial of AMG 386 for treatment of recurrent ovarian cancer http://goo.gl/fb/vAkMj
Updated AMG 386 Data Demonstrate Promising Antitumor Activity in Patients With Recurrent Ovarian Cancer - Drugs.com MedNews
drugs.com — “THOUSAND OAKS, Calif., Amgen (Nasdaq AMGN) today announced AMG 386, combined with paclitaxel, demonstrated antitumor activity in a randomized Phase 2 trial invo” View full resource at drugs.com
Most Recently Shared on October 11, 2010 at 11:06 pm By:
Drugs and Devices OW OW Health
Updated AMG 386 Data Demonstrate Promising Antitumor Activity in Patients With Recurrent Ovarian Cancer: THOU... http://bit.ly/b2PL9F #drug
Updated AMG 386 Data Demonstrate Promising Antitumor Activity in Patients With Recurrent Ovarian Cancer - Health News - redOrbit
redorbit.com — “THOUSAND OAKS, Calif., Oct. 9 /PRNewswire/ -- Amgen (Nasdaq: AMGN) today announced AMG 386, combined with paclitaxel, demonstrated antitumor activity in a randomized Phase 2 trial involving 161 patients with recurrent ovarian cancer.” View full resource at redorbit.com
Most Recently Shared on October 9, 2010 at 3:29 pm By:
Updated AMG 386 Data Demonstrate Promising Antitumor Activity in Patients With Recurrent Ovarian Cancer: THOUSAND ... http://bit.ly/bNeRSv
Phase 2 trial of AMG 386 for treatment of recurrent ovarian cancer - MPR
empr.com — “Amgen announced that AMG 386, combined with paclitaxel, demonstrated antitumor activity in a randomized Phase 2 trial involving 161 patients with recurrent ovarian cancer.” View full resource at empr.com
Most Recently Shared on June 7, 2010 at 8:14 pm By:
MPR News: Phase 2 trial of AMG 386 for treatment of recurrent ovarian cancer: Amgen announced that AMG 386, combin... http://bit.ly/cBbIUj
Advertisement
